NCT02453191: A trial that was reported late by University of Iowa
This trial has reported, although it was 112 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02453191 |
|---|---|
| Title | Neoadjuvant Intralesional Injection of Talimogene Laherparepvec With Concurrent Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | July 13, 2015 |
| Completion date | Jan. 22, 2019 |
| Required reporting date | Jan. 22, 2020, midnight |
| Actual reporting date | May 13, 2020 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | 112 |